ArticleMolecular medicine (Cambridge, Mass.)2025
Developing a disease-specific accessible transcriptional signature as a biomarker for ataxia with oculomotor apraxia type 2.
Kathie J Ngo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.